The Confidence to Know Bleeding Will Stop

We developed the Veriset™ haemostatic patch based on six years of scientific research and development. It’s designed to help you achieve haemostasis quickly and consistently.([FOOTNOTE=Öllinger R, Mihaljevic AL, Schuhmacher C, et al. A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery [published online Dec. 27, 2012]. HPB (Oxford). 2013;15(7):548-58. doi: 10.1111/hpb.12009.],[ANCHOR=],[LINK=])

The Veriset™ haemostatic patch is not available for sale in the United States.


Fast and Reliable

  • 75% of patients achieve haemostasis in approximately 1 minute1
  • Hold for only 30 seconds([FOOTNOTE=Based on Veriset™ haemostatic patch instructions for use and product specifications. 2014.],[ANCHOR=],[LINK=])

Increased Patient Safety

  • 100% free of human or animal components, eliminating risk of viral transmission2


  • Effective in cases of inhibited coagulation, independent of clotting ability([FOOTNOTE=Sponsored preclinical study assessing CV and PV models on animals with inhibited platelet activity (heparin, aspirin, Plavix™*). 2010. ],[ANCHOR=],[LINK=])
  • Significantly superior performance compared to TachoSil™*1,([FOOTNOTE=Based on internal test study #COVEUCV0140-CSR, Study to compare the Veriset™ hemostatic patch to TachoSil™* as an adjunct to hemostasis in subjects undergoing cardiovascular surgery. March 2014. Data on file.],[ANCHOR=],[LINK=])


  • Can be used in both open and laparoscopic procedures2
  • Easily passes through trocar([FOOTNOTE=Based on internal study #TR1478, Evaluating Veriset™ hemostatic patch after laparoscopic liver resection in a porcine model. 2013.],[ANCHOR=],[LINK=])

Order Information


Increase Patient Safety2

Unlike any other high-efficacy haemostat, Veriset™ patch is 100% free of human components2 - eliminating the risk of viral transmission.

   1. Oxidized regnerated cellulose (Layer 1)

  • 3-D pattern allows for blood absorption
  • Known to promote haemostasis via a reduction in blood pH
  • Acts as a tamponade

   2. Trilysine (Layer 2)

  • Combines with the PEG to form a hydrogel barrier

   3. Reactive polyethylene glycol (PEG) (Layer 3)

  • Propriety sealant technology
  • Effective barrier to blood flow
  • Adheres the patch to the bleeding site

Universal UseΩ

Effective in cases of inhibited coagulation and independent of clotting ability.6

   1. Placement

  • PEG side (darker) of the Veriset™ patch placed against the bleeding site2
  • Blood whisks into the patch and it becomes compliant

   2. Pressure

  • The oxidized regenerated cellulose within the patch absorbs blood and initiates the coagulation process by a reduction in blood pH

   3. Polymerization

  • Polymer components cross-link to form an impenetrable barrier (hydrogel).2 It then adheres to the bleeding site

   4. Haemostasis

  • Haemostasis is achieved in approximately 1 minute1

   5.  Absorption

  • Veriset™ patch is fully absorbed in approximately 4 weeks2

Easy to Use1,2

  • No special storage requirements guarantees easy access when needed2
  • Ready to use in both open and laparoscopic procedures with no preparation time2


  • 6. Based on internal preclinical study assessing CV and PV models on animals with inhibited platelet activity (heparin, aspirin, Plavix™*). 2010.

  • Ω Based on serum plasma morphology.